| Verification, analytical validation, and clinical validation (V3): the foundation of determining fit-for-purpose for Biometric Monitoring Technologies (BioMeTs) JC Goldsack, A Coravos, JP Bakker, B Bent, AV Dowling, C Fitzer-Attas, ... npj digital Medicine 3 (1), 55, 2020 | 397 | 2020 |
| Digital medicine: a primer on measurement A Coravos, JC Goldsack, DR Karlin, C Nebeker, E Perakslis, ... Digital biomarkers 3 (2), 31-71, 2019 | 153 | 2019 |
| Digital measures that matter to patients: a framework to guide the selection and development of digital measures of health C Manta, B Patrick-Lake, JC Goldsack Digital Biomarkers 4 (3), 69-77, 2020 | 122 | 2020 |
| Advancing digital health applications: priorities for innovation in real-world evidence generation AD Stern, J Brönneke, JF Debatin, J Hagen, H Matthies, S Patel, I Clay, ... The Lancet Digital Health 4 (3), e200-e206, 2022 | 117 | 2022 |
| Hourly rounding and patient falls: what factors boost success? J Goldsack, M Bergey, S Mascioli, J Cunningham Nursing2025 45 (2), 25-30, 2015 | 95 | 2015 |
| Influence of surgical and minimally invasive facial cosmetic procedures on psychosocial outcomes: a systematic review S Imadojemu, DB Sarwer, I Percec, SS Sonnad, JE Goldsack, M Berman, ... JAMA dermatology 149 (11), 1325-1333, 2013 | 87 | 2013 |
| Use of mobile devices to measure outcomes in clinical research, 2010–2016: a systematic literature review B Perry, W Herrington, JC Goldsack, CA Grandinetti, KP Vasisht, ... Digital Biomarkers 2 (1), 11-30, 2018 | 84 | 2018 |
| Modernizing and designing evaluation frameworks for connected sensor technologies in medicine A Coravos, M Doerr, J Goldsack, C Manta, M Shervey, B Woods, ... NPJ digital medicine 3 (1), 37, 2020 | 81 | 2020 |
| Continuous sound collection using smartphones and machine learning to measure cough L Kvapilova, V Boza, P Dubec, M Majernik, J Bogar, J Jamison, ... Digital biomarkers 3 (3), 166-175, 2020 | 77 | 2020 |
| Impact of shortages of injectable oncology drugs on patient care JC Goldsack, C Reilly, C Bush, S McElligott, MN Bristol, UN Motanya, ... American journal of health-system pharmacy 71 (7), 571-578, 2014 | 68 | 2014 |
| Advancing the use of mobile technologies in clinical trials: recommendations from the clinical trials transformation initiative P Coran, JC Goldsack, CA Grandinetti, JP Bakker, M Bolognese, ... Digital Biomarkers 3 (3), 145-154, 2020 | 62 | 2020 |
| Considerations for development of an evidence dossier to support the use of mobile sensor technology for clinical outcome assessments in clinical trials MK Walton, JC Cappelleri, B Byrom, JC Goldsack, S Eremenco, D Harris, ... Contemporary Clinical Trials 91, 105962, 2020 | 54 | 2020 |
| A systematic review of feasibility studies promoting the use of mobile technologies in clinical research JP Bakker, JC Goldsack, M Clarke, A Coravos, C Geoghegan, A Godfrey, ... NPJ digital medicine 2 (1), 47, 2019 | 54 | 2019 |
| Invisible work and changing roles: Health information technology implementation and reorganization of work practices for the inpatient nursing team MR Bergey, JC Goldsack, EJ Robinson Social science & medicine 235, 112387, 2019 | 53 | 2019 |
| Clinical, patient experience and cost impacts of performing active surveillance on known methicillin-resistant Staphylococcus aureus positive patients admitted to medical … JC Goldsack, C DeRitter, M Power, A Spencer, CL Taylor, SF Kim, R Kirk, ... American journal of infection control 42 (10), 1039-1043, 2014 | 53 | 2014 |
| Precompetitive consensus building to facilitate the use of digital health technologies to support Parkinson disease drug development through regulatory science D Stephenson, R Alexander, V Aggarwal, R Badawy, L Bain, R Bhatnagar, ... Digital biomarkers 4 (Suppl. 1), 28-49, 2020 | 52 | 2020 |
| Evaluation, acceptance, and qualification of digital measures: from proof of concept to endpoint JC Goldsack, AV Dowling, D Samuelson, B Patrick-Lake, I Clay Digital biomarkers 5 (1), 53-64, 2021 | 50 | 2021 |
| Outcomes of in-person and telehealth ambulatory encounters during COVID-19 within a large commercially insured cohort E Hatef, D Lans, S Bandeian, EC Lasser, J Goldsack, JP Weiner JAMA network open 5 (4), e228954-e228954, 2022 | 43 | 2022 |
| A writing group for female assistant professors SS Sonnad, J Goldsack, KL McGowan Journal of the National Medical Association 103 (9-10), 811-815, 2011 | 41 | 2011 |
| Defining and developing the workforce needed for success in the digital era of medicine JC Goldsack, CA Zanetti Digital biomarkers 4 (Suppl 1), 136, 2020 | 38 | 2020 |